NRD
KURA icon

Nebula Research & Development’s Kura Oncology KURA Stock Holding History

Nebula Research & Development’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121,884
Closed -$703K – 473
2025
Q2 		$703K Buy
121,884
+64,460
+112% +$395K 0.06% 526
2025
Q1 		$379K Sell
57,424
-6,442
-10% -$50.2K 0.04% 694
2024
Q4 		$556K Buy
+63,866
New +$919K 0.07% 516

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nebula Research & Development's KURA Position: Q3 2025 in Review

Nebula Research & Development sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 121,884 shares — an estimated $703K sold.

Nebula Research & Development first reported a position in KURA in Q4 2024 and held it in 3 quarters. The position peaked at $703K in Q2 2025. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Nebula Research & Development reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 121,884 Kura Oncology shares in Q3 2025, an estimated $703K.
  • Nebula Research & Development first reported a position in Kura Oncology in Q4 2024 and held it in 3 quarters.
  • Nebula Research & Development's Kura Oncology position peaked at $703K in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.